Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
T-Mobile US Inc
TMUS
Technology
Communication Equipment
T-Mobile US, Inc. is a provider of mobile communications services, including voice, messaging and data, under its flagship brands, T-Mobile and Metro by T-Mobile in the United States, Puerto Rico and the United States Virgin Islands. The Company provides mobile communications services primarily using its 4G Long Term Evolution (LTE) network and its 5G technology network. It also offers a...
selection of wireless devices, including handsets, tablets and other mobile communication devices, and accessories for sale, as well as financing through equipment installment plans (EIP). The Company’s primary service plan offering is Go5G Plus, which includes unlimited talk, text and data on its network, 5G access at no extra cost, scam protection features and more. In addition to its mobile wireless communications services, the Company also offers high speed Internet, which includes a fixed wireless product that utilizes the excess capacity of its nationwide 5G network.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (NDAQ:TMUS)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
Next
(23)
•••
TradeVision2001
X
View Profile
View Bullboard History
Post by
TradeVision2001
on Nov 27, 2024 6:56pm
TMUS Subscriber Growth is Insane!
TMUS added more postpaid subs in Q3 than Verizon and AT&T combined! The 5G rollout and aggressive promos are clearly paying off. Holding long—growth still looks solid. Also watching BOLT, hearing
...more
(291)
•••
whytestocks
X
View Profile
View Bullboard History
Post by
whytestocks
on Oct 24, 2024 3:31pm
TMUS Price Target Alert: $230.00. Issued by Barclays
NEWS: $TMUS TMUS Price Target Alert: $230.00. Issued by Barclays2024-10-24 10:59:53 ET Kannan Venkateshwar from Barclays issued a price target of $230.00 for TMUS on 2024-10-24 09:08:00. The adjusted
...more
(291)
•••
whytestocks
X
View Profile
View Bullboard History
Post by
whytestocks
on Oct 22, 2024 10:30pm
Update on T-Mobile's Efforts Following Hurricanes Helene and
Breaking News: $TMUS Update on T-Mobile's Efforts Following Hurricanes Helene and MiltonNORTHAMPTON, MA / ACCESSWIRE / October 22, 2024 / Our hearts continue to be with everyone in the Southeast
...more
(9)
•••
MikeTester
X
View Profile
View Bullboard History
Post by
MikeTester
on Aug 03, 2024 9:35am
T-Mobile US, Inc. (NASDAQ:TMUS): Delivering Consistent Profi
https://beyondspx.com/2024/08/02/t-mobile-us-inc-nasdaqtmus-delivering-consistent-profitable-growth-and-expanding-fiber-footprint/
(574)
•••
greendaze
X
View Profile
View Bullboard History
Post by
greendaze
on Dec 25, 2023 4:10pm
Tesla , StarLink , TMUS , deal in the works ?
I've only found one source so far . Still digging . Source says the chips are already in the cars.
(0)
•••
MarcLee
X
View Profile
View Bullboard History
Post by
MarcLee
on Apr 13, 2023 4:08am
Kevin Harrington Discusses FSD Pharma
I believe this new product will aid society in reducing the
...more
(0)
•••
MarcLee
X
View Profile
View Bullboard History
Post by
MarcLee
on Jul 15, 2022 9:43pm
FSD Pharma Subsidiary Lucid Psycheceuticals Files for Patent
(0)
•••
MarcLee
X
View Profile
View Bullboard History
Post by
MarcLee
on Jun 03, 2022 5:27am
FSD Will Proceed with Phase2 of FSD-201 Soon After Clearance
FSD Pharma ready to proceed with Phase 2 clinical trial of
...more
(0)
•••
MarcLee
X
View Profile
View Bullboard History
Post by
MarcLee
on Jun 02, 2022 12:37am
FSD Pharma Files Investigational New Drug Application “IND”
(0)
•••
MarcLee
X
View Profile
View Bullboard History
Post by
MarcLee
on May 11, 2022 1:51am
FSD Pharma Closes CAD$16.4 Million Sale of Non-Core Assets
(0)
•••
MarcLee
X
View Profile
View Bullboard History
Post by
MarcLee
on May 02, 2022 8:22pm
Lucid-MS for Multiple Sclerosis Treatment
(0)
•••
MarcLee
X
View Profile
View Bullboard History
Post by
MarcLee
on Apr 25, 2022 2:31am
"Julia Levy Award" Recipient David Allan and Dr. John McGraw
(0)
•••
MarcLee
X
View Profile
View Bullboard History
Post by
MarcLee
on Apr 18, 2022 2:38am
FSD Pharma Inc: Lucid MS Video
FSD Pharma is delighted to announce pre-clinical findings
...more
(0)
•••
MarcLee
X
View Profile
View Bullboard History
Post by
MarcLee
on Apr 09, 2022 12:51pm
FSD: Cancellation of Certain Shares Issued to Former CEO
FSD Pharma Announces Cancellation of Certain Shares Issued to Former Chief Executive Officer Dr. Raza Bokhari TORONTO--(BUSINESS WIRE)--FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A)
...more
(0)
•••
MarcLee
X
View Profile
View Bullboard History
Post by
MarcLee
on Apr 07, 2022 12:44pm
FSD Pharma Issues Corporate Updates
FSD Pharma Issues Corporate Updates TORONTO--(BUSINESS WIRE)--FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) (“FSD Pharma” or the “Company”), a life sciences holding company dedicated to
...more
Prev
1
2
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Why Dozens of Pro Athletes are Paying Attention to this Product
Do you want to stay ahead of the markets? See how DealRoom can help.
Debt-Free Cannabis Company Set for Next Stage of Growth
Growth Rocket 2025 – Why dynaCERT is in the Spotlight
Learn How this Company is Disrupting Point-of-Care Testing